Related Experiment Video
Updated: May 5, 2026

Author Spotlight: Anterior HR-OCT as a Non-Invasive Tool for Characterizing Ocular Surface Squamous Neoplasia
Published on: August 9, 2024
Resolution of conjunctival sessile hemangioma with topical timolol
Jordon G Lubahn1, Richard K Lee, Carol L Karp
1Bascom Palmer Eye Institute, University of Miami Miller School of Medicine, Miami, FL.
Purpose:
To report a single case of acquired sessile hemangioma of the conjunctiva which resolved after treatment with topical timolol.
Methods:
Case report and literature review.
Results:
A 77-year-old African American woman developed an acquired sessile hemangioma of the conjunctiva of the right eye. She was followed for primary open-angle glaucoma, and the lesion was monitored for 12 months without change. Topical timolol-dorzolamide was then added to her glaucoma medication regimen twice daily. On follow-up examination 6 months later, the lesion had completely resolved.
Conclusions:
In this case report, an acquired sessile hemangioma of the conjunctiva resolved with topical timolol therapy.
Related Concept Videos
Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...
Angle Closure Glaucoma: Treatment
Glaucoma: Overview

